Verruguin Liquid Wart Remover

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common warts, which are characterized by their rough, “cauliflower-like” surface appearance.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed and dried thoroughly prior to application. One drop of the medication should be applied at a time using the provided applicator to ensure sufficient coverage of each wart. After application, the area should be allowed to dry completely.

This procedure may be repeated once or twice daily as needed, for a maximum duration of up to 2 weeks.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame.

The product should not be applied in or near the eyes or mucous membranes, on irritated skin, or if there is a known allergy to any ingredient in this formulation. It is contraindicated for use on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Additionally, it should not be used on any area that is infected or reddened, nor on large areas of the body if the patient is diabetic or has poor blood circulation. The product is also not suitable for application on wounds or damaged skin.

When using this product, if it comes into contact with the eyes, it is imperative to flush the eyes with water for at least 15 minutes. Inhalation of vapors should be avoided. The bottle should be capped tightly and stored at room temperature, away from heat sources.

If discomfort persists after application, the patient should seek medical advice. Users are advised to discontinue use and consult a healthcare professional if irritation occurs, if the condition worsens or does not improve, or if discomfort continues. Pregnant or breastfeeding individuals should consult a healthcare professional prior to use.

This product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware of several important warnings associated with the use of this product. It is intended for external use only and is flammable; therefore, it should be kept away from fire or flame. The product should not be used in or near the eyes or mucous membranes, on irritated skin, or if the patient is prone to allergic reactions to any ingredient in the formulation. Additionally, it should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. The product is contraindicated for use on any area that is infected or reddened, and it should not be used by individuals who are diabetic or have poor blood circulation, particularly on large areas of the body, wounds, or damaged skin.

While using this product, if it comes into contact with the eyes, it is advised to flush the eyes with water for 15 minutes. Patients should avoid inhaling vapors and ensure that the bottle is tightly capped and stored at room temperature, away from heat sources. If discomfort persists, patients are encouraged to consult their doctor.

Patients should discontinue use and seek medical advice if irritation occurs, if the condition worsens or does not improve, or if discomfort persists. Pregnant or breastfeeding individuals should consult a healthcare professional before using this product. It is essential to keep the product out of reach of children, and in the event of accidental ingestion, medical help should be sought immediately or contact with a Poison Control Center should be made.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Verruguin Liquid Wart Remover (salisylic acid 17%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center without delay. Prompt action is crucial to mitigate potential risks associated with overdosage.

Healthcare professionals should be aware that symptoms of overdosage may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is essential. Management procedures should include supportive care and symptomatic treatment as necessary. Continuous monitoring of the patient's vital signs and clinical status is recommended to ensure appropriate interventions are implemented in a timely manner.

In all cases of suspected overdosage, the involvement of poison control experts can provide valuable guidance on specific management strategies tailored to the individual situation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, patients should be instructed to seek medical help or contact a Poison Control Center immediately. It is important for patients to understand the potential risks associated with improper use and to take necessary precautions to ensure safety.

Storage and Handling

The product is supplied in a tightly capped bottle. It is essential to store the product at a temperature range of 20º to 25ºC (68º to 77ºF). To ensure safety and efficacy, the product should be used in a well-ventilated area, and inhalation of vapors should be avoided. Users are advised to retain the original packaging for complete labeling information.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Verruguin Liquid Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)